FDA Finalizes Guidance On ‘Unique Challenges’ Of Psychedelic Research And Schedules Hearing On Therapeutic Uses
November 5, 1996 Canada’s drug policy review: Who’s Who on the review A mailing list of all of the Members of Parliament on the Standing Committee on Health